Repositorio Dspace

Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer

Mostrar el registro sencillo del ítem

dc.contributor.author Ruiz-Lorente, Inmaculada
dc.contributor.author Gimeno-Arias, Lourdes
dc.contributor.author López-Abad, Alicia
dc.contributor.author López-Cubillana, Pedro
dc.contributor.author Fernández-Aparicio, Tomás
dc.contributor.author Asensio-Egea, Lucas-Jesús
dc.contributor.author Moreno-Avilés, Juan
dc.contributor.author Doñate-Íñiguez, Gloria
dc.contributor.author Guzmán-Martínez-Valls, Pablo-Luis
dc.contributor.author Server, Gerardo
dc.contributor.author Ferri-Ñíguez, Belén
dc.contributor.author Campillo, José-Antonio
dc.contributor.author Galindo, Francisco
dc.contributor.author Boix-Giner, Francisco
dc.contributor.author Martínez-Sánchez, María-Victoria
dc.contributor.author Martínez-Hernández, María-Dolores
dc.contributor.author Minguela-Puras, Alfredo
dc.date.accessioned 2026-03-09T08:29:56Z
dc.date.available 2026-03-09T08:29:56Z
dc.date.issued 2025-09-04
dc.identifier.citation Ruiz-Lorente I, Gimeno L, López-Abad A, López Cubillana P, Fernández Aparicio T, Jesús Asensio Egea L, et al. Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer. Front Cell Dev Biol. 4 de septiembre de 2025;13:1632101. doi:10.3389/fcell.2025.1632101
dc.identifier.issn 2296-634X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/24945
dc.description.abstract INTRODUCTION: Tobacco smoking is the most significant risk factor for bladder cancer (BC), followed by other environmental and dietary exposures. However, major genetic determinants remain unidentified. The objective of this work was to investigate the potential association of killer-cell immunoglobulin-like receptor 2DL5 (KIR2DL5) with BC risk, its interaction with tobacco smoking, and the underlying immune mechanisms. METHODS: This case-control study analyzed KIR genotype in patients with BC (n = 325), as well as in healthy controls (HC, n = 925) and patients with other cancers (n = 862) as control groups. Immune assays assessed proliferation, cytotoxicity, cytokine, and intracellular nitric oxide (icNO) production by NK and T cells after anti-CD3/CD28 or Bacillus Calmette-Guérin (BCG) stimulation in 24 donors stratified by KIR2DL5 genotype. Multivariate logistic regression was used to evaluate BC predisposition. RESULTS: The frequency of KIR2DL5 was higher in BC patients than in HC (64.6% vs. 53.6%, p = 0.004). Linear regression analysis revealed that, independent of other aKIRs within the B haplotype, KIR2DL5 was associated with BC susceptibility (HR = -1.167, p = 0.050), alongside other significant factors such as sex (HR = -1.465, p < 0.001), age (HR = -0.181, p < 0.001), and tobacco smoking (HR = -2.454, p < 0.001). The frequency of KIR2DL5 was higher among non-smokers compared to smokers in both healthy controls (61.4% vs. 44.6%, p < 0.05) and BC patients (72.9% vs. 60.8%, p < 0.05). Among non-smoking BC patients, KIR2DL5 was more frequently observed in small-sized (<3 cm), solid-pattern, non-muscle-invasive BC cases. Immune profiling revealed that KIR2DL5 was associated with increased icNO production by NK and T cells but showed no association with proliferation, cytokine secretion, or cytotoxicity. DISCUSSION: KIR2DL5 is independently associated with BC, regardless of age, sex, or tobacco smoking status. While the immunological mechanisms remain unclear, enhanced nitric oxide production by immune effector cells may play a role in this association.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es
dc.title Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 40977889
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fcell.2025.1632101/full
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.3389/fcell.2025.1632101
dc.journal.title Frontiers in Cell and Developmental Biology


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta